Intra-Cellular Therapies, Inc.
Total Trades
140
Buys
0
Sells
74
Largest Trade
N/A
Insiders
8
Institutional Funds
1
Inst. Value
$1K–$15K
Activist Filings
11
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Halstead Michael | President | EXERCISE | $1M+ | 42K | $29.77 | Nov 14, 2024 |
| Halstead Michael | President | SELL | $1M+ | 42K | $88.79 | Nov 14, 2024 |
| Mates Sharon | Chairman and CEO | SELL | $1M+ | 70K | $72.70 | Aug 30, 2024 |
| Mates Sharon | Chairman and CEO | EXERCISE | $500K+ | 70K | $12.73 | Aug 30, 2024 |
| Mates Sharon | Chairman and CEO | EXERCISE | $1M+ | 96K | $17.57 | Aug 28, 2024 |
| Mates Sharon | Chairman and CEO | SELL | $1M+ | 96K | $73.54 | Aug 28, 2024 |
| Mates Sharon | Chairman and CEO | SELL | $1M+ | 121K | $75.05 | Aug 23, 2024 |
| Mates Sharon | Chairman and CEO | EXERCISE | $1M+ | 121K | $17.57 | Aug 23, 2024 |
| Neumann Mark | EVP | SELL | $1M+ | 19K | $75.08 | Aug 20, 2024 |
| Neumann Mark | EVP | EXERCISE | $500K+ | 19K | $36.89 | Aug 20, 2024 |
| RIGGS RORY B | Director | EXERCISE | $100K–$500K | 22K | $15.63 | Jun 25, 2024 |
| RIGGS RORY B | Director | SELL | $100K–$500K | 4K | $75.57 | Jun 25, 2024 |
| VAN NOSTRAND ROBERT L | Director | SELL | $1M+ | 20K | $75.91 | Jun 21, 2024 |
| VAN NOSTRAND ROBERT L | Director | EXERCISE | $100K–$500K | 20K | $16.86 | Jun 21, 2024 |
| VAN NOSTRAND ROBERT L | Director | EXERCISE | $100K–$500K | 20K | $18.56 | Feb 29, 2024 |
| VAN NOSTRAND ROBERT L | Director | SELL | $1M+ | 20K | $72.93 | Feb 29, 2024 |
| Halstead Michael | EVP and General Co… | EXERCISE | N/A | 8K | — | Feb 28, 2024 |
| Halstead Michael | EVP and General Co… | SELL | $500K+ | 8K | $69.53 | Feb 28, 2024 |
| Hineline Lawrence J. | SVP of Finance, CFO | EXERCISE | $100K–$500K | 13K | $16.27 | Feb 28, 2024 |
| Hineline Lawrence J. | SVP of Finance, CFO | SELL | $500K+ | 13K | $69.43 | Feb 28, 2024 |
| Mates Sharon | Chairman | SELL | $1M+ | 23K | $69.79 | Feb 28, 2024 |
| Mates Sharon | Chairman | EXERCISE | N/A | 23K | — | Feb 28, 2024 |
| Durgam Suresh K. | EVP | SELL | $100K–$500K | 4K | $70.17 | Feb 28, 2024 |
| Durgam Suresh K. | EVP | EXERCISE | N/A | 8K | — | Feb 28, 2024 |
| Neumann Mark | EVP | SELL | $500K+ | 8K | $70.13 | Feb 28, 2024 |
| Neumann Mark | EVP | EXERCISE | N/A | 8K | — | Feb 28, 2024 |
| MARCUS JOEL S | Director | SELL | $1M+ | 26K | $68.68 | Feb 28, 2024 |
| MARCUS JOEL S | Director | EXERCISE | $1M+ | 37K | $48.93 | Feb 28, 2024 |
| Halstead Michael | EVP and General Co… | GRANT | N/A | 12K | — | Feb 5, 2024 |
| Halstead Michael | EVP and General Co… | SELL | $500K+ | 12K | $66.42 | Feb 5, 2024 |
| Mates Sharon | Chairman | GRANT | N/A | 34K | — | Feb 5, 2024 |
| Mates Sharon | Chairman | SELL | $1M+ | 34K | $67.07 | Feb 5, 2024 |
| Neumann Mark | EVP | GRANT | N/A | 12K | — | Feb 5, 2024 |
| Neumann Mark | EVP | SELL | $500K+ | 12K | $67.15 | Feb 5, 2024 |
| Hineline Lawrence J. | SVP of Finance, CFO | SELL | $500K+ | 11K | $66.62 | Feb 5, 2024 |
| Hineline Lawrence J. | SVP of Finance, CFO | GRANT | N/A | 11K | — | Feb 5, 2024 |
| Durgam Suresh K. | EVP | SELL | $100K–$500K | 6K | $67.19 | Feb 5, 2024 |
| Durgam Suresh K. | EVP | GRANT | N/A | 12K | — | Feb 5, 2024 |
| Mates Sharon | Chairman | SELL | $1M+ | 191K | $66.27 | Jan 19, 2024 |
| Mates Sharon | Chairman | EXERCISE | $1M+ | 191K | $16.86 | Jan 19, 2024 |
| Halstead Michael | EVP and General Co… | EXERCISE | $500K+ | 50K | $13.60 | Jan 12, 2024 |
| Halstead Michael | EVP and General Co… | SELL | $1M+ | 50K | $66.83 | Jan 12, 2024 |
| Durgam Suresh K. | EVP | SELL | $1M+ | 62K | $70.60 | Jan 5, 2024 |
| Durgam Suresh K. | EVP | EXERCISE | $1M+ | 62K | $19.87 | Jan 5, 2024 |
| Halstead Michael | EVP and General Co… | EXERCISE | $500K+ | 50K | $13.56 | Nov 14, 2023 |
| Halstead Michael | EVP and General Co… | SELL | $1M+ | 50K | $53.90 | Nov 14, 2023 |
| Neumann Mark | EVP | SELL | $1M+ | 42K | $55.63 | Nov 8, 2023 |
| Neumann Mark | EVP | EXERCISE | $500K+ | 27K | $23.94 | Nov 8, 2023 |
| Mates Sharon | Chairman | SELL | $1M+ | 100K | $53.94 | Sep 20, 2023 |
| Neumann Mark | EVP | SELL | $1M+ | 55K | $58.79 | Aug 9, 2023 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 1 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $1K–$15K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Jun 5, 2025
0.0%
0 shares
SC 13G/A · Feb 7, 2025
2.5%
2.7M shares
SC 13G/A · Nov 12, 2024
10.5%
11.1M shares
SC 13G/A · Nov 8, 2024
5.9%
6.2M shares
SC 13G/A · Oct 24, 2024
5.9%
6.2M shares
JPMORGAN CHASE & CO. 13-2624428
SC 13G · Oct 10, 2024
5.0%
5.3M shares
The Vanguard Group - 23-1945930
SC 13G/A · Feb 13, 2024
9.4%
9.1M shares
SC 13G/A · Jan 25, 2024
8.5%
8.2M shares
SC 13G/A · Feb 3, 2023
7.9%
7.4M shares
Wasatch Advisors LP 87-0319391
SC 13G/A · Jan 10, 2023
5.0%
4.7M shares
Wasatch Advisors, Inc. 87-0319391
SC 13G/A · Feb 10, 2022
10.1%
8.2M shares